Recruiting studies
Heart failure with preserved or slightly reduced ejection fraction and Obesity
Study
Participate in our clinical trial to evaluate the effectiveness of a combined therapeutic approach for weight loss in adults living with heart failure.
The situation
Living with heart failure presents daily challenges, and being overweight or obese can increase the workload on your heart.
Finding suitable solutions to promote weight loss while safely and rigorously managing heart health is a priority for current medical research.
The study objective
The research team is preparing a clinical trial to evaluate the effectiveness of a combined treatment.
This protocol aims to analyze the effects of weight loss and support for the management of heart failure in participants with both conditions.
What participating in this study means:
- Free access to treatment: Eligible participants will have free access to the study's combined medication for weight loss and heart failure management.
- Specialized medical supervision: You will benefit from regular follow-ups and examinations related to the clinical study, fully supervised by our healthcare professionals.
- Contribution to science: Your participation helps advance medical knowledge about the interactions between weight management and cardiovascular health.
- No hidden costs: The visits, examinations, and follow-ups required by the study protocol are provided at no cost to the participant.
- Compensation: Financial compensation is provided to cover your time and travel expenses.
Eligibility and Voluntary Participation
Participation in this research is entirely voluntary. You may withdraw from the study at any time, without providing a reason and without affecting the quality of your future care. Each medical profile is rigorously reviewed by our team of professionals.
To be eligible, you must:
- Be 18 years of age or older.
- Have an official diagnosis of heart failure.
- Have a body mass index (BMI) of ≥30.0 kg/m².
Would you like more information?
Our recruitment team is available to explain the study process, answer your questions, and confirm your eligibility.
Complete the eligibility form.
I want to apply to this clinical study
Participate in the study of Sherbrooke (East) Participate in the study of Trois-Rivières
For more information, contact us at
819 346-2887 (Sherbrooke (East)), 819 801-9797 (Trois-Rivières)
or at 1-844-739-3439 (toll free), or fill the online form.
The study process in pictures
Explanation
Step 1 | Before starting the study, we will take time to fully explain the selection process and the conduct of the study by phone.
Meeting
Step 2 | After the initial phone interview, if you are still interested in taking part in a study, we schedule a preliminary meeting with you during which you may ask all the questions you wish and take the time you require to read over the consent form. This form explains, in detail, the different stages of each study.
Decision
Step 3 | You may make a decision at that time to move forward with or terminate the selection process. However, you are under no obligation to make an immediate decision. Based on briefing content, you may take the time necessary to come to a decision and consult with your personal physician or loved ones.
Tests
Step 4 | Depending on the nature of the study, some tests or medical examinations may be required. In the majority of cases, these tests or examinations are conducted on Diex Research premises based on your individual availability.
Departure
Step 5 | If you are eligible, you may then begin a clinical study with us.
